Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Doreen L. D'Souza"'
Autor:
Lorinda Simms, Kevin M. Koch, James Nezamis, Doris K. Robbins, Dan C. Dimmitt, Doreen L. D'Souza
Publikováno v:
The Journal of Clinical Pharmacology. 41:455-458
Lotronex® (alosetron hydrochloride) is a 5-HT3 receptor antagonist indicated for the treatment of irritable bowel syndrome (IBS) in females whose predominant bowel habit is diarrhea. Alosetron is extensively metabolized by multiple cytochrome P450 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2046fa719958501bb038ae5f040e2826
https://doi.org/10.1177/00912700122010177
https://doi.org/10.1177/00912700122010177
Autor:
James Nezamis, Lorinda Simms, Doris K. Robbins, Kevin M. Koch, Laurence M. Levasseur, Doreen L. D'Souza
Publikováno v:
The Journal of Clinical Pharmacology. 41:452-454
Lotronex (alosetron hydrochloride) is a 5-HT3 receptor antagonist indicated for the treatment of irritable bowel syndrome (IBS) in females whose predominant bowel habit is diarrhea. Alosetron is extensively metabolized by multiple cytochrome P450 (CY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f65e3925502e9488e7d9d263e7ccbb2
https://doi.org/10.1177/00912700122010168
https://doi.org/10.1177/00912700122010168